Experienced in Febrile Neutropenia

Dr. Mitchell E. Gross

Oncology
Providence
12414 Exposition Boulevard, 
Los Angeles, CA 
Accepting New Patients
Offers Telehealth

Experienced in Febrile Neutropenia
Providence
12414 Exposition Boulevard, 
Los Angeles, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mitchell Gross is an Oncologist in Los Angeles, California. Dr. Gross is rated as an Experienced provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Febrile Neutropenia, and Breast Cancer. Dr. Gross is currently accepting new patients.

His clinical research consists of co-authoring 52 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Febrile Neutropenia.

Specialties
Oncology
Licenses
Specialist in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 1 Less Insurance Carrier -

Locations

12414 Exposition Boulevard, Los Angeles, CA 90064
Call: 310-272-7640

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

A Phase 1, First-in-human, Open-label, Dose Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral TP-1287 to Patients with Advanced Solid Tumors
A Phase 1, First-in-human, Open-label, Dose Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral TP-1287 to Patients with Advanced Solid Tumors
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: TP-1287
Study Phase: Phase 1
Phase 2 Trial of Phenelzine in Non-metastatic Recurrent Prostate Cancer
Phase 2 Trial of Phenelzine in Non-metastatic Recurrent Prostate Cancer
Enrollment Status: Completed
Publish Date: December 12, 2022
Intervention Type: Drug, Other
Study Drug: Phenelzine sulfate
Study Phase: Phase 2
A Phase IB Open-label, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK525762 in Combination With Androgen Deprivation Therapy and Other Agents in Subjects With Castrate-resistant Prostate Cancer (CRPC)
A Phase IB Open-label, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK525762 in Combination With Androgen Deprivation Therapy and Other Agents in Subjects With Castrate-resistant Prostate Cancer (CRPC)
Enrollment Status: Terminated
Publish Date: August 10, 2022
Intervention Type: Drug
Study Drugs: GSK525762, Abiraterone, Enzalutamide, Prednisone
Study Phase: Phase 1
Assessment of Novel Biomarkers in Patients With Metastatic Castration Resistant Prostate Cancer
Assessment of Novel Biomarkers in Patients With Metastatic Castration Resistant Prostate Cancer
Enrollment Status: Terminated
Publish Date: April 17, 2017
Intervention Type: Other
View 3 Less Clinical Trials

52 Total Publications

EphB4-ephrin-B2 are targets in castration resistant prostate cancer.
EphB4-ephrin-B2 are targets in castration resistant prostate cancer.
Journal: British journal of cancer
Published: June 01, 2024
View All 52 Publications
Similar Doctors
Distinguished in Febrile Neutropenia
Dr. Boris Bagdasarian
Oncology | Hematology
Distinguished in Febrile Neutropenia
Dr. Boris Bagdasarian
Oncology | Hematology
1505 Wilson Terrace, Suite 200, 
Glendale, CA 
 (13.5 miles away)
818-409-0105
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Boris Bagdasarian is a Hematologist and an Oncologist in Glendale, California. Dr. Bagdasarian is rated as a Distinguished provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Agranulocytosis, Chronic Familial Neutropenia, Langerhans Cell Histiocytosis, and Thrombocytopenia. Dr. Bagdasarian is currently accepting new patients.

Distinguished in Febrile Neutropenia
Dr. Mihran H. Shirinian
Hematology Oncology | Oncology | Hematology
Distinguished in Febrile Neutropenia
Dr. Mihran H. Shirinian
Hematology Oncology | Oncology | Hematology
1505 Wilson Ter, Suite 340, 
Glendale, CA 
 (13.5 miles away)
818-543-7574
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mihran Shirinian is a Hematologist Oncology specialist and an Oncologist in Glendale, California. Dr. Shirinian is rated as a Distinguished provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Acute Erythroid Leukemia (AEL), Colorectal Cancer, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.

Advanced in Febrile Neutropenia
Dr. Lasika C. Seneviratne
Oncology | Hematology Oncology
Advanced in Febrile Neutropenia
Dr. Lasika C. Seneviratne
Oncology | Hematology Oncology
1245 Wilshire Boulevard, Suite 303, 
Santa Monica, CA 
 (9.2 miles away)
213-977-1214
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lasika Seneviratne is a Hematologist Oncology specialist and an Oncologist in Santa Monica, California. Dr. Seneviratne is rated as a Distinguished provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Agranulocytosis, and Inflammatory Breast Cancer. Dr. Seneviratne is currently accepting new patients.

VIEW MORE FEBRILE NEUTROPENIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gross's expertise for a condition
ConditionClose
    • Distinguished
    • Prostate Cancer
      Dr. Gross is
      Distinguished
      . Learn about Prostate Cancer.
      See more Prostate Cancer experts
    • Advanced
    • Familial Prostate Cancer
      Dr. Gross is
      Advanced
      . Learn about Familial Prostate Cancer.
      See more Familial Prostate Cancer experts
    • Experienced
    • Agranulocytosis
      Dr. Gross is
      Experienced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • Bone Tumor
      Dr. Gross is
      Experienced
      . Learn about Bone Tumor.
      See more Bone Tumor experts
    • Breast Cancer
      Dr. Gross is
      Experienced
      . Learn about Breast Cancer.
      See more Breast Cancer experts
    • Febrile Neutropenia
      Dr. Gross is
      Experienced
      . Learn about Febrile Neutropenia.
      See more Febrile Neutropenia experts
    • Lung Cancer
      Dr. Gross is
      Experienced
      . Learn about Lung Cancer.
      See more Lung Cancer experts
    • Pleuropulmonary Blastoma
      Dr. Gross is
      Experienced
      . Learn about Pleuropulmonary Blastoma.
      See more Pleuropulmonary Blastoma experts
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.